Subscribe by Email

Your email:

Coldstream Laboratories Blog

Current Articles | RSS Feed RSS Feed

Coldstream Expands Business Development Group


LEXINGTON, KY--Coldstream Laboratories, Inc., a provider of parenteral manufacturing and sterile drug product development services, announced that Jason Dwinell has joined the Business Development Group in the role of Business Development Manager.  In this position, Mr. Dwinell will primarily represent the territory west of the Rocky Mountains.

Coldstream Laboratories Completes Successful FDA Inspection


LEXINGTON, KY., Apr 21, 2014 (GLOBE NEWSWIRE) --Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced the completion of a successful inspection by the Food and Drug Administration (FDA). Coldstream hosted FDA authorities from April 8 – 17, 2014, at its manufacturing facility in Lexington, KY. The site audit reviewed quality systems to ensure compliance with current Good Manufacturing Practices (cGMPs).  

Coldstream Laboratories Third-Time Winner of CMO Leadership Award

parenteral contract manufacturing
LEXINGTON, KY (April 10, 2014)  Coldstream Laboratories, Inc., a provider of sterile drug product development and parenteral manufacturing services is a winner of Life Science Leader’s annual CMO Leadership Awards for the third consecutive year. 

The CMO Leadership Awards are presented by Life Science Leader magazine and were developed to assist pharmaceutical and biotech companies in identifying reliable and reputable contract manufacturing partners.  All research and results are compiled by Nice Insight, with voters being those organizations seeking CMO services.  The official award website states:

Coldstream Announces Key Quality Certifications for Team Members


LEXINGTON, KY--(Marketwired – February 5, 2014) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced certifications for four key members of its Quality Assurance Team.

Coldstream Laboratories Names Director of Formulation Development


Adrian Raiche, Ph.D. Named as Director of Formulation Development at Coldstream Laboratories, Inc.

Coldstream to Exhibit at World ADC Conference

antibody drug conjugates

Coldstream and Goodwin Biotechnology will co-exhibit at the World ADC Summit in San Francisco, CA, from October 14th to 17th.  Please meet us at Booth #13 to discuss your cytotoxic antibody drug conjugation needs.

Coldstream Laboratories Awarded 5-Year Contract With the National Cancer Institute


LEXINGTON, KY--(Marketwired - Sep 24, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that they have been awarded a 5-year contract with the National Cancer Institute ("NCI") under solicitation number N02CM37007-11 (contract# HHSN261201300031I) entitled "Development and Production of Parenteral Dosage Forms for Clinical Studies."

Coldstream Laboratories Expands Business Development Group

sterile manufacturing

Pamela Savoy Added as Director of Business Development at Coldstream Laboratories, Inc.

Coldstream to Attend Generics Conference


Christopher A. Verbicky, Ph.D., MBA, will be attending the “6th Product and Pipeline Enhancement for Generics Conference” in this week in Washington, D.C.  The event will take place at the Sheraton Crystal City Hotel July 23 – 25, 2013.

Goodwin Biotechnology and Coldstream Laboratories Announce a Collaboration to Develop and Manufacture Cytotoxic Antibody Drug Conjugates

antibody drug conjugates

Plantation, Florida and Lexington, Kentucky-- Goodwin Biotechnology, Inc. (GBI) and Coldstream Laboratories, Inc. have established a collaboration for developing and manufacturing high-potency, highly cytotoxic materials (e.g., small molecules, protein toxins, cytotoxic antibody drug conjugates, and other bioconjugates).

All Posts